Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep 18;10(4):300-304.
doi: 10.1055/s-0040-1716707. eCollection 2021 Dec.

Diagnosis is in the Eye of the Beholder: Barriers to Early Diagnosis of Mucopolysaccharidosis in Children in India

Meenu Grewal  1 , Mamta Muranjan  1
Affiliations

Diagnosis is in the Eye of the Beholder: Barriers to Early Diagnosis of Mucopolysaccharidosis in Children in India

Meenu Grewal et al. J Pediatr Genet. .

Abstract

The present study examined referral pattern and diagnostic practices for mucopolysaccharidosis (MPS) in India in 40 patients with a confirmed diagnosis. Time lag between age of onset of symptoms and consultation with primary physician ranged from 0 to 84 months, between consultation with primary physician and visit to genetic clinic of 0 to 128 months, from visit to genetic clinic and diagnosis of 1 to 111 months, and that between onset of symptoms and diagnosis 1 to 154 months. Major causes for delayed diagnosis were symptoms overlooked by physician (54%), late consultation by care giver (48.6%), late onset of symptoms (43.2%), and resource crunch (32.4%). Diagnosis at referral other than MPS was noted in 45%. Thus, diagnostic delay for MPS is common due to health seeking practices of parents, as well as physicians' clinical practices. Overcoming these barriers would necessitate strengthening awareness and educational activities for physicians and lay public.

Keywords: glycosaminoglycans; inborn errors of metabolism; lysosomal storage disorders.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

Similar articles

See all similar articles

Cited by

References

    1. Valayannopoulos V, Wijburg F A. Therapy for the mucopolysaccharidoses. Rheumatology (Oxford) 2011;50 05:v49–v59. - PubMed
    1. Sheth J, Mistri M, Sheth F. Burden of lysosomal storage disorders in India: experience of 387 affected children from a single diagnostic facility. JIMD Rep. 2014;12:51–63. - PMC - PubMed
    1. Verma P K, Ranganath P, Dalal A B, Phadke S R. Spectrum of lysosomal storage disorders at a medical genetics center in northern India. Indian Pediatr. 2012;49(10):799–804. - PubMed
    1. Kadali S, Kolusu A, Gummadi M R, Undamatla J. The relative frequency of lysosomal storage disorders: a medical genetics referral laboratory's experience from India. J Child Neurol. 2014;29(10):1377–1382. - PubMed
    1. Beck M, Arn P, Giugliani R. The natural history of MPS I: global perspectives from the MPS I Registry. Genet Med. 2014;16(10):759–765. - PMC - PubMed